marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Acasti Pharma Financial Ratios 2011-2024 | ACST
Annual Financial Ratios Acasti Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.6 | -2.1 | -0.8 | - | -1.2 | -0.8 | -1603.8 | -3.5 | -38.5 | -9.3 | -23.0 | -21.6 | - |
P/S |
- | 0.2 | 75.7 | - | - | - | - | 579.3 | 235.6 | 215.5 | 219.1 | 1110.7 | - |
EPS |
-0.9 | -0.3 | -1.3 | -0.3 | -0.7 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
7.83 M | 10.3 M | -29.3 M | 41.1 M | 73.1 M | 24.9 M | 13.6 B | 17.1 M | 54.1 M | 108 M | 157 M | 142 M | 5.24 M |
EBITDA per Share |
-1.17 | - | -1.1 | - | -0.571 | -0.801 | - | -0.5 | -0.757 | -0.961 | -0.848 | -0.874 | - |
EV/EBITDA |
1.8 | - | -1.0 | -0.6 | -2053.1 | -2.6 | -6.2 | -11.9 | -24.9 | -23.7 | - | ||
PEG |
- | - | -0.05 | - | 434302.82 | -0.03 | 0.22 | -0.11 | 0.53 | -1.71 | - | ||
P/B |
0.4 | 0.2 | 0.3 | 4.3 | 4.5 | 2.1 | 831.1 | 0.8 | 1.9 | 3.2 | 16.3 | 9.7 | - |
P/CF |
-1.5 | -1.2 | -1.0 | -35.0 | -1.9 | -1.3 | -1901.8 | -3.1 | -8.8 | -15.5 | -59.8 | -25.0 | - |
ROE % |
-62.44 | -9.07 | -35.35 | - | -369.33 | -261.48 | -51.82 | -23.21 | -4.98 | -34.89 | -70.88 | -44.93 | - |
ROA % |
-53.62 | -7.63 | -31.51 | - | -106.39 | -93.66 | -44.18 | -22.15 | -4.45 | -25.45 | -56.63 | -41.33 | - |
ROCE % |
-76.75 | -14.40 | -29.50 | - | -145.66 | -121.12 | -48.79 | -35.11 | -34.83 | -24.29 | -71.78 | -45.01 | - |
Current Ratio |
7.1 | 6.3 | 9.2 | - | 2.0 | 1.4 | 4.8 | 9.9 | 12.1 | 22.0 | 2.4 | 7.0 | - |
DSO |
- | 2.0 | 1001.9 | - | - | - | - | 3865.7 | 1152.6 | 838.2 | 421.3 | 3127.2 | - |
DIO |
- | - | - | - | - | - | - | - | 135.6 | 327.0 | 199.5 | 43096.6 | - |
DPO |
- | - | 4389.6 | - | - | - | - | 1682.0 | 382.7 | 399.8 | 292.0 | 39486.5 | - |
Operating Cycle |
- | 2.0 | 1001.9 | - | - | - | - | 3865.7 | 1288.2 | 1165.2 | 620.9 | 46223.8 | - |
Cash Conversion Cycle |
- | 2.0 | -3387.7 | - | - | - | - | 2183.6 | 905.5 | 765.4 | 328.8 | 6737.3 | - |
All numbers in USD currency
Quarterly Financial Ratios Acasti Pharma
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.3 | -0.24 | -0.21 | -0.43 | -0.54 | - | -0.52 | -0.66 | -0.61 | - | -0.09 | -0.23 | -0.07 | - | -0.26 | -0.03 | -0.06 | -0.05 | -0.14 | -0.25 | -0.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.45 | - | - | -0.6 | - | -0.57 | -0.67 | -0.62 | - | -0.1 | -0.43 | -0.23 | - | -0.16 | -0.02 | -0.08 | -0.04 | -0.07 | -0.07 | -0.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-19.12 | -19.29 | -18.91 | -19.23 | -19.25 | -13.28 | -16.68 | -16.06 | -16.32 | -14.41 | -26.94 | -36.06 | -43.40 | -94.31 | -136.59 | 158.52 | 2958.66 | 2757.82 | 2443.68 | 2161.09 | -626.52 | -356.41 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-16.33 | -16.59 | -16.16 | -16.35 | -16.24 | -11.03 | -14.33 | -14.31 | -15.17 | -13.40 | -24.03 | -31.35 | -49.69 | -64.42 | -84.84 | -74.21 | -50.93 | -127.11 | -213.39 | -213.39 | -106.69 | -106.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-24.81 | -23.16 | -19.19 | -18.87 | -20.84 | -14.02 | -18.05 | -17.69 | -22.38 | -26.38 | -34.02 | -37.63 | -35.47 | -105.82 | -143.16 | 7.74 | 839.49 | 685.57 | 722.92 | 579.65 | -244.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
7.1 | 6.7 | 6.6 | 6.8 | 8.1 | 7.1 | 5.8 | 5.8 | 6.1 | 6.3 | 36.1 | 21.4 | 8.6 | 9.2 | 6.6 | 2.8 | 2.2 | 2.3 | - | - | - | 1.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 700.7 | 630.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 718.5 | 630.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 718.5 | 630.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency